Rosuvastatin for Prevention of Anthracycline-induced Cardiac Dysfunction in Breast Cancer Patients
Rosuvastatin for Prevention of Anthracycline-induced Cardiac Dysfunction in Breast Cancer Patients
Not yet recruiting · NCT07254221 · Registry updated 2025-12-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Rosuvastatin for Prevention of Anthracycline-induced Cardiac Dysfunction in Breast Cancer Patients | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, cardiovascular disorder, heart disorder, injury, neoplasm, radiation injury, skin disorder | Not yet recruiting | Phase 4 | 2025-12-10 | NCT07254221 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shiraz University of Medical Sciences | 4 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Kowsar Hospital, Fars Heart Foundation | Shiraz | Iran | 1 |
| Modarres Hospital, Shahid Beheshti University of Medical Sciences | Tehran | Iran | 1 |
| Motahari Breast Cancer Clinic | Shiraz | Iran | 1 |
| Rajaee Hospital, Iran University of Medical Sciences | Tehran | Iran | 1 |
| Sina Hospital, Tehran University of Medical Sciences | Tehran | Iran | 1 |
| Taleghani Hospital, Shahid Beheshti University of Medical Sciences | Tehran | Iran | 1 |
| Toba Oncology Department, Mazandaran University of Medical Sciences | Sari | Iran | 1 |